Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac Resynchronization Therapy for Heart Failure.

Heather M. Ross1, Dusan Z. Kocovic

  • 1Main Line Health Heart Center, 556 Lankenau Medical Office Building East, 100 Lancaster Avenue, Wynnewood, PA 19096, USA. kocovicd@casep.com

Current Treatment Options in Cardiovascular Medicine
|August 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weight Loss During Topiramate Treatment in a Severely Obese Adolescent with Congenital Adrenal Hyperplasia and Migraine

Journal of clinical research in pediatric endocrinologyยท2021
See all related articles

Cardiac resynchronization therapy (CRT) improves severe heart failure outcomes by reducing hospitalizations. Advanced CRT devices also aid in predicting and managing heart failure decompensation and arrhythmias.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is a key treatment for severe heart failure.
  • Improved lead delivery systems and increased implanter experience expand patient access to CRT.
  • Ongoing research focuses on optimizing implantation techniques and device technology.

Purpose of the Study:

  • To evaluate the impact of CRT on heart failure management.
  • To explore the diagnostic capabilities of CRT devices.
  • To assess the long-term cost-effectiveness and patient benefits of CRT.

Main Methods:

  • Transvenous left ventricular lead implantation.
  • Utilizing diagnostic tools within implanted CRT devices.
  • Analyzing patient outcomes including emergency room visits and hospitalizations.

Related Experiment Videos

Main Results:

  • CRT typically decreases emergency room visits and hospitalizations for heart failure decompensation.
  • CRT devices facilitate prediction of heart failure decompensation and management of arrhythmias.
  • Potential for long-term healthcare cost savings and improved patient outcomes.

Conclusions:

  • CRT is an effective therapy for severe heart failure, reducing healthcare utilization.
  • Advanced CRT devices offer valuable diagnostic capabilities for proactive patient management.
  • CRT may evolve into a secondary prevention strategy, postponing heart failure progression.